| SYS | | 0083167 |
|---|
| LBL | | 00000naa^^22^^^^^^^^450 |
|---|
| 005 | | 20121217144908.8 |
|---|
| 100 | | $a 20121207a2012 m y0sloy0103 ba |
|---|
| 101 | 0- | $a eng $d eng |
|---|
| 102 | | $a SK |
|---|
| 200 | 1- | $a Down-regulation of TCF21 is associated with poor survival in clear cell renal cell carcinoma $f Y.W. Ye ... [et al.] |
|---|
| 215 | | $c ilustr., obr., grafy, tab. |
|---|
| 320 | | $a Bibliogr. odkazy |
|---|
| 320 | | $a Res. angl. |
|---|
| 463 | -1 | $1 001 sllk_un_cat*0081995 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 59, no. 6 (2012), s. 599-605 $1 210 $a Bratislava $c AEPress $d 2012 $1 215 $a s. 599-761 |
|---|
| 541 | 1- | $a Down regulácia TCF21 je spojená so zlým prežitím pri renálnom karcinóme zo svetlých buniek $z slo |
|---|
| 606 | 1- | $3 sllk_un_auth*d002292 $a karcinóm renálnych buniek $x diagnostika $x patológia $2 mesh |
|---|
| 606 | 1- | $3 sllk_un_auth*d018262 $a adenokarcinóm svetlobunkový $x patológia $2 mesh |
|---|
| 606 | 1- | $3 sllk_un_auth*d014157 $a faktory transkripčné $x analýza $2 mesh |
|---|
| 606 | 2- | $3 sllk_un_auth*d007150 $a imunohistochémia $2 mesh |
|---|
| 606 | 2- | $3 sllk_un_auth*d015870 $a expresia génu $2 mesh |
|---|
| 606 | 2- | $3 sllk_un_auth*d019175 $a metylácia DNA $2 mesh |
|---|
| 606 | 2- | $3 sllk_un_auth*d011379 $a prognóza $2 mesh |
|---|
| 610 | 2- | $a faktor transkripčný TCF21 |
|---|
| 701 | -1 | $3 sllk_un_auth*0027629 $a Ye $b Y.W. $4 070 |
|---|
| 701 | -1 | $3 sllk_un_auth*0027630 $a Jiang $b Z. M. $4 070 |
|---|
| 701 | -1 | $3 sllk_un_auth*0027632 $a Li $b W. H. $4 070 |
|---|
| 701 | -1 | $3 sllk_un_auth*0027633 $a Li $b Z. S. $4 070 |
|---|
| 701 | -1 | $3 sllk_un_auth*0027634 $a Han $b Y. H. $4 070 |
|---|
| 701 | -1 | $3 sllk_un_auth*0020205 $a Sun $b L. $4 070 $p Guangdong key laboratory of male reproductive medicine and genetics, Peking university Shenzen hospital, Shenzen, China |
|---|
| 701 | -1 | $3 sllk_un_auth*0020206 $a Wang $b Y. $4 070 $p Guangdong key laboratory of male reproductive medicine and genetics, Peking university Shenzen hospital, Shenzen, China |
|---|
| 701 | -1 | $3 sllk_un_auth*0027635 $a Xie $b J. $4 070 |
|---|
| 701 | -1 | $3 sllk_un_auth*0027636 $a Liu $b Y. C. $4 070 |
|---|
| 701 | -1 | $3 sllk_un_auth*0027637 $a Zhao $b J. $4 070 |
|---|
| 701 | -1 | $3 sllk_un_auth*0027638 $a Tang $b A. F. $4 070 |
|---|
| 701 | -1 | $3 sllk_un_auth*0027639 $a Li $b X. X. $4 070 |
|---|
| 701 | -1 | $3 sllk_un_auth*0027346 $a Guan $b Z. $4 070 |
|---|
| 701 | -1 | $3 sllk_un_auth*0020207 $a Gui $b Y. $p Guangdong key laboratory of male reproductive medicine and genetics, Peking university Shenzen hospital, Shenzen, China $4 070 |
|---|
| 701 | -1 | $3 sllk_un_auth*0020208 $a Cai $b Z. $4 070 $p Guangdong key laboratory of male reproductive medicine and genetics, Peking university Shenzen hospital, Shenzen, China |
|---|
| 801 | -0 | $a SK $b BA006 $c 20121207 $g AACR2 |
|---|
